Genetics in eye diseases: towards a new model of medicine

Medical content revised by - Last revision 15/04/2019
Genetics in eye diseases: towards a new model of medicine

Times change and we are slowly moving towards precision medicine. In the field of diseases that affect vision, knowledge about its genetic basis has grown exponentially in recent years. Genetic diagnostic tests have undergone a revolution with the techniques of massive sequencing and the possibilities of treatment with gene therapy begin to be an emerging reality.

What is a genetic disease?

It is the disease caused, totally or partially, by an alteration in the normal sequence of DNA. Most genetic diseases are multifactorial, which means that they are caused by a combination of alterations in several genes and various environmental factors.

Are there many vision disorders that have a genetic component?

Yes. On the one hand, it has been shown that in very frequent visual diseases, such as glaucoma (which affects around 65 million people worldwide) or age-related macular degeneration (AMD, which affects about 30 million people around the world), there is a high genetic susceptibility. On the other hand, the number of so-called rare diseases (those that affect less than 1 out of 2,000 inhabitants) known at present is approximately 7,000. Although each of these rare diseases affects a small percentage of the general population, if we add them all, we find that, as a whole, they affect more than 300 million people around the world. And 5% of these rare diseases are genetic disorders that affect vision.

Is it easy to make the genetic diagnosis of these diseases?

The genetic diagnosis of these diseases is not easy. On the one hand, more than 500 genes that can cause vision problems have been described. On the other hand, each of these genes can present different variations (mutations). In addition, as we have already said, most diseases are caused by the interaction of different factors, both genetic and environmental. Therefore the finding of a mutation in one of these genes, by itself, usually is not enough to confirm unambiguously that the patient suffers from a certain disease, but that is only one more piece (a key one though) of the puzzle that we must put together to explain the alteration that the patient suffers.

Is it important to make the genetic diagnosis?

Yes, particularly in cases of rare diseases that affect vision, whose diagnosis represents a special challenge for the doctor who treats the patient. This can be due to the rarity of the disease and because, in many cases, when the patient goes to the consultation room the pathology is in a very advanced state and the ophthalmological findings are not specific to one disorder. Sometimes these represent a situation of tissue atrophy that may have been reached from different origins and caused by different diseases. In these cases, the findings of specific mutations may be the key piece that we lacked in order to confirm the diagnosis.

When we have the confirmation that a patient is a carrier of a certain genetic alteration, we can advise him on changes in his diet or habits that may influence the likelihood of a certain disease manifesting or help change a prognosis.

Some people also want genetic counseling because they consider having biological offspring and, in these cases, it is essential to have confirmation of the genetic diagnosis.

Is there any gene therapy at present for these disorders?

In December of 2017 a milestone was marked in the history of Medicine and, in particular, of Ophthalmology, with the approval by the FDA (Food and Drug Administration) of the first gene therapy administered directly. It is an approved medication for patients with retinal dystrophy associated with the RPE65 mutation. There are also several clinical trials in research for other pathologies, some of them in advanced stages, such as those that are being carried out for Leber Hereditary Optic Neuropathy (LHON).

Post your comment

In accordance with the provisions of the General Data Protection Regulation (REGULATION (EU) 2016/679), the following information about the processing of personal data is disclosed to you.

Responsible: Institut Català de la Retina, S.L., Institut Català de Cirurgia refractiva, S.L. (from now on ICR)

Representative of Data Protection Contact: C/Pau Alcover nº 67 08017 Barcelona –

Aim: The purpose of the treatment is to manage the information you provide us and after having your consent, publish the testimonial on our website.

Legitimization: The legal basis for the present treatment is the request made by you and having your consent.

Recipients: The recipients of the information are the departments and delegations in which ICR is organized, in part or in its entirety. It will not be communicated to third parties.

Rights: At any time, you can exercise your rights of access, rectification, deletion, opposition, limitation of treatment and / or portability of data by writing to the RPD Representative of Data Protection at the address provided in contact. You can also revoke consents to other treatments. You can also request more information from the RPD about the treatments performed.
In the event that you consider that your rights have been violated, you can submit a claim to the competent Data Protection Control Authority.

For all purposes, the user accepts that the opinion expressed will be exclusively his /her responsibility. The user assumes under his / her exclusive responsibility the damages or harms that may derive from it.
ICR will not be responsible for the accuracy, quality, reliability, correctness, morality and legality of the data, information or opinions published by users.
ICR reserves the right not to publish all opinions of users.
The user is solely responsible of his /her username. ICR will not be responsible for the illegal use or for illicit purposes that other users can make of this user name.

Preservation: The collected data will be kept during the time required for the requested management, for at most 30 days.

ICR Ganduxer Headquarters

08022 Barcelona

ICR Pau Alcover

C. Pau Alcover 67
08017 Barcelona

ICR Terrassa

C. del Nord, 77
08221 Terrassa

Clínica Bonanova Surgical Center

Passeig Bonanova, 22
08022 Barcelona

Clinica Bonanova Tests and Treatments

c/ Mandri, 63
08022 Barcelona

ICR Service at Clínica Ntra. Sra. del Remei

c/ de l'Escorial,148
08024 Barcelona
This website uses cookies in order to collect statistical information regarding navigation. If you keep on surfing this website, it shall be deemed to have acknowledged its use. More information.